Top Markets
#1 Helium Helium +54.24%
#2 TENDIES TENDIES +42.67%
#3 Pons Pons +31.17%
#4 UnifAI Network UnifAI Network +19.26%
#5 Seeker Seeker +18.62%
#6 Songbird Songbird +12.62%
#7 Lista DAO Lista DAO +11.02%
#8 OSK OSK +10.04%
#9 DAPPOS DAPPOS +9.30%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +8.97%
Coin of the day
Helium Helium
設定
言語
日本
通貨
USD
テーマ
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
株式のランク #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
株価
$14.66
最終同期: 2026-08-28
時価総額
$839.37M
変化（1日）
-2.67%
変化（1年）
557.32%
国
US
取引 Climb Bio, Inc. (CLYM)

カテゴリー

Healthcare
Climb Bio, Inc.（CLYM）の株価履歴
終値の最高値: $15.73 （2026-08-01）

終値の最安値: $7.23 （2024-09-01）
Climb Bio, Inc. の株価履歴（2024 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 113.43%
2025 31.56%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH